A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Although not available in India, new weight loss drugs Ozempic and Wegovy are all the rage. Lounge speaks to doctors about ...

The popularity of weight loss drugs has soared during the past few years as new injectable medications have appeared as an effective and safe solution to obesity. But while these drugs may be one of ...

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

The effectiveness can vary based on the individual response and adherence to treatment. Research indicates that GLP-1 ...

The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...

The surging popularity of weight-loss drugs, expected to be a $150 billion market by early 2030s, has whetted investor appetite in companies looking to tap into the boom. BioAge priced its offering of ...

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

By Arasu Kannagi Basil and Prakhar Srivastava (Reuters) -Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer ...